Protect Minors from Medical Malpractice Act of 2025
Protect Minors from Medical Malpractice Act of 2025
Plain Language Summary
# Bill Summary: Protect Minors from Medical Malpractice Act of 2025 **What the bill would do:** This bill would hold medical practitioners legally responsible for 30 years if they perform gender-transition procedures on patients under 18, making them liable for any physical, psychological, emotional, or physiological harms that result. The bill also would penalize states by cutting off federal health funding if they require doctors to perform such procedures.
The bill defines gender-transition procedures as certain surgeries or hormone therapies intended to change a person's body to match a gender identity different from their biological sex, though it excludes treatments for intersex conditions and medical treatments for infections or injuries. **Who it affects:** This bill primarily affects minors (people under 18) seeking gender-transition treatments, medical practitioners who provide these treatments, and state governments. It would create potential legal and financial consequences for doctors and states, while restricting access to these medical options for young people. **Current status:** The bill was introduced in the 119th Congress by Representative Brian Babin (R-TX) and is currently in committee, meaning it has not yet been debated or voted on by the full House of Representatives.
CRS Official Summary
Protect Minors from Medical Malpractice Act of 2025This bill makes a medical practitioner who performs a gender-transition procedure on an individual who is less than 18 years of age liable for any physical, psychological, emotional, or physiological harms from the procedure for 30 years after the individual turns 18.Additionally, if a state requires medical practitioners to perform gender-transition procedures, that state shall be ineligible for federal funding from the Department of Health and Human Services.Under the bill, gender-transition procedures generally include certain surgeries or hormone therapies that change the body of an individual to correspond to a sex that is discordant with the individual's biological sex. They exclude, however, interventions to treat (1) individuals who either have ambiguous external biological sex characteristics or lack a normal sex chromosome structure, sex steroid hormone production, or sex steroid hormone action; (2) infections, injuries, diseases, or disorders caused by a gender-transition procedure; or (3) a physical disorder, injury, or illness that places an individual in imminent danger of death or impairment of a major bodily function.
Latest Action
Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, Education and Workforce, Natural Resources, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.